Comparative Evaluation of Tacrolimus 0.1% in Orabase and Triamcinolone Acetonide 0.1% in the Management of Recurrent Apthous Stomatitis (RAS) - A Case Control Study

比较0.1%他克莫司口腔软膏和0.1%曲安奈德治疗复发性阿弗他溃疡(RAS)的疗效——一项病例对照研究

阅读:1

Abstract

BACKGROUND: Recurrent apthous stomatitis (RAS) and recurrent apthous ulcers are common oral ulcers which are associated with a significant amount of pain and reduction in quality of life, where traditional mainstay of treatment is topical steroids. METHODOLOGY: A case control study was undertaken on 90 patients seeking treatment for minor RAS and was divided into three groups. An index ulcer was selected and treated with 0.1% tacrolimus, 0.1% triamcinolone acetonide, and placebo, respectively, for 1 week. RESULTS: At the end of day 2, the mean percentage reduction was 44.16%, 79.82% at day 5 and 94.26% at day 7 in the tacrolimus group, which was comparatively higher than the other two groups at day 2, day 5, and day 7. Recurrence was reported in all three groups but was not statistically significant. CONCLUSION: The results of the study suggest that 0.1% tacrolimus is more effective as an immediate mode of treatment than 0.1% triamcinolone acetonide or placebo in the management of recurrent aphthous ulcers.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。